bortezomib teva 1 mg por oldatos injekcióhoz
teva gyógyszergyár zrt. - bortezomib -
bortezomib teva 2,5 mg por oldatos injekcióhoz
teva gyógyszergyár zrt. - bortezomib -
tabinaz 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz
proterapia hungary kft. - bendamustine-hidroklorid-monohidrát -
bortezomib ebewe 3,5 mg por oldatos injekcióhoz
sandoz hungária kft. - bortezomib -
bortezomib sandoz 3,5 mg por oldatos injekcióhoz
sandoz hungária kft. - bortezomib -
bendamustine onkogen 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz
onkogen kft. - bendamustine-hidroklorid-monohidrát -
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunszuppresszánsok - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
bendamustine accord 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz
accord healthcare polska sp. z o.o. - bendamustine-hidroklorid-monohidrát -
bendamustine accord 25 mg/ml koncentrátum oldatos infúzióhoz
accord healthcare polska sp. z o.o. - bendamustine-hidroklorid-monohidrát -